
ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027
Asia Pacific Neurostimulation Device Market by System (Spinal Cord Stimulators (Scs), Deep Brain Stimulators (Dbs), Sacral Nerve Stimulators (Sns), Vagus Nerve Stimulators (Vns), Gastric Electric Stimulator, Other System) by Applications (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Other Applications) by Geography.
Neurostimulation is the process of involving an implantable medical device to modulate and alter neural activities for therapeutic purposes. The implantable devices used for neurostimulation are referred to as neurostimulation devices or Neurostimulator. The neurostimulation device implantation process is minimally invasive, and the growing demand for such surgeries is expected to increase the market penetration rates of these devices. Improvements in healthcare infrastructure & the high prevalence of lifestyle diseases leading to increased surgeries and chronic disorders will be propelling market growth at a CAGR of 11.20% in the Asia Pacific region during the forecasting years of 2019-2027.
The growing confidence of physicians in the use of neurostimulation devices is also expected to enforce the market to progress. India neurostimulation device market is mainly driven owing to initiatives taken by the state governments, rising prevalence of stroke along with the initiatives taken by foreign private organizations operating in the country. According to the World Health Organization, the prevalence rate for stroke accounts for 58 per 100000 among the population of the country. The individuals aged above 55 years are more prone to be impacted strokes in the country which is fueling the demand & adoption of neurostimulation devices market in India.
Many companies are contending in the race to gain the maximum sum of profits. Some of them are Cogentix Medical Inc., St. Jude Medical Inc. (acquired by Abbott Laboratories), Aleva Neurotherapeutics SA, Boston Scientific Corporation, Helius Medical Technologies, The Magstim Company Limited, Cyberonics Inc., Neuronetics Inc., Depuy Synthes Companies, Ekso Bionics Holding Inc., Medtronic PLC, Dr. Langer Medical GmBH, Ectron Limited, Nevro Corp. and Hocoma AG.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- SPINAL CORD STIMULATORS HOLDS THE LARGEST MARKET SHARE IN TERMS OF NEUROSTIMULATION SYSTEM
- PAIN MANAGEMENT IS THE MAJORLY USED NEUROSTIMULATION APPLICATION
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- HIGH OCCURRENCE OF NEURO DISEASES
- DEVELOPMENTS IN TECHNOLOGY
- RISING DEMAND FOR MINIMALLY INVASIVE SURGERIES
- HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION
- INCREASING GERIATRIC POPULATION
- FAVORABLE REIMBURSEMENT AND INSURANCE APPROVAL POLICIES
- MARKET RESTRAINTS
- HIGH PRICE OF NEUROMODULATION TREATMENT
- SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION DEVICES
- ANONYMOUS APPLIANCE OF SCS THERAPY
- STRINGENT REGULATORY APPROVALS
- MARKET OPPORTUNITIES
- DEVELOPMENT OF INDICATION FOR SCS
- INCREASING THE DEMAND FOR NEUROSTIMULATION DEVICES WITHSTANDING MRI SCANS
- GROWING OCCURRENCE OF CHRONIC DISCOMFORT
- MARKET CHALLENGES
- OBTAINABILITY OF ALTERNATIVE THERAPY
- SAFETY CONCERNS
- MARKET BY SYSTEM
- SPINAL CORD STIMULATORS (SCS)
- DEEP BRAIN STIMULATORS (DBS)
- SACRAL NERVE STIMULATORS (SNS)
- VAGUS NERVE STIMULATORS (VNS)
- GASTRIC ELECTRIC STIMULATOR
- OTHER SYSTEM
- MARKET BY APPLICATIONS
- PAIN MANAGEMENT
- EPILEPSY
- ESSENTIAL TREMOR
- URINARY AND FECAL INCONTINENCE
- DEPRESSION
- DYSTONIA
- GASTROPARESIS
- PARKINSON’S DISEASE
- OTHER APPLICATIONS
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF BUYERS
- THREAT OF RIVALRY
- ESTIMATION ANALYSIS
- INCREASING PREVALENCE OF MENTAL HEALTH PROBLEMS
- RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
- RISING GERIATRIC POPULATION
- VALUE CHAIN ANALYSIS
- PESTLE ANALYSIS
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- COMPETITIVE LANDSCAPE
- MARKET SHARE ANALYSIS
- COMPANY PROFILES
- ALEVA NEUROTHERAPEUTICS SA
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BOSTON SCIENTIFIC CORPORATION
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- COGENTIX MEDICAL INC.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CYBERONICS INC.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- DEPUY SYNTHES COMPANIES
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- LANGER MEDICAL GMBH
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- ECTRON LIMITED
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- EKSO BIONICS HOLDING INC.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- HELIUS MEDICAL TECHNOLOGIES
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- HOCOMA AG
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- MEDTRONIC PLC
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- NEURONETICS INC.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- NEVRO CORP.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- JUDE MEDICAL INC. (ACQUIRED BY ABBOTT LABORATORIES)
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- THE MAGSTIM COMPANY LIMITED
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- ALEVA NEUROTHERAPEUTICS SA
LIST OF TABLES
TABLEÂ 1Â Â Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
TABLEÂ 2Â Â Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLEÂ 3Â Â Â Â Â Â ASIA PACIFIC SPINAL CORD STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLEÂ 4Â Â Â Â Â Â ASIA PACIFIC DEEP BRAIN STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLEÂ 5Â Â Â Â Â Â ASIA PACIFIC SACRAL NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLEÂ 6Â Â Â Â Â Â ASIA PACIFIC VAGUS NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLEÂ 7Â Â Â Â Â Â ASIA PACIFIC GASTRIC ELECTRIC STIMULATOR MARKET 2019-2027 ($ MILLION)
TABLEÂ 8Â Â Â Â Â Â ASIA PACIFIC OTHER SYSTEM MARKET 2019-2027 ($ MILLION)
TABLEÂ 9Â Â Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLEÂ 10Â Â Â Â ASIA PACIFIC PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)
TABLEÂ 11Â Â Â Â ASIA PACIFIC EPILEPSY MARKET 2019-2027 ($ MILLION)
TABLEÂ 12Â Â Â Â ASIA PACIFIC ESSENTIAL TREMOR MARKET 2019-2027 ($ MILLION)
TABLEÂ 13Â Â Â Â ASIA PACIFIC URINARY AND FECAL INCONTINENCEÂ MARKET 2019-2027 ($ MILLION)
TABLEÂ 14Â Â Â Â ASIA PACIFIC DEPRESSION MARKET 2019-2027 ($ MILLION)
TABLEÂ 15Â Â Â Â ASIA PACIFIC DYSTONIAÂ MARKET 2019-2027 ($ MILLION)
TABLEÂ 16Â Â Â Â ASIA PACIFIC GASTROPARESIS MARKET 2019-2027 ($ MILLION)
TABLE 17    ASIA PACIFIC PARKINSON’S DISEASE MARKET 2019-2027 ($ MILLION)
TABLEÂ 18Â Â Â Â ASIA PACIFIC OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLEÂ 19Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027, (IN $ BILLION)
TABLEÂ 20Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)
LIST OF FIGURES
FIGUREÂ 1Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGUREÂ 2Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET SHARE BY SYSTEM 2018 & 2027 (%)
FIGUREÂ 3Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)
FIGUREÂ 4Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)
FIGUREÂ 5Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGUREÂ 6Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGUREÂ 7Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)
FIGUREÂ 8Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)
FIGUREÂ 9Â Â Â Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET SHARE BY APPLICATIONS 2018 & 2027 (%)
FIGUREÂ 10Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)
FIGUREÂ 11Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY EPILEPSYÂ 2019-2027 ($ MILLION)
FIGUREÂ 12Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)
FIGUREÂ 13Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCEÂ 2019-2027 ($ MILLION)
FIGUREÂ 14Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)
FIGUREÂ 15Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY DYSTONIAÂ 2019-2027 ($ MILLION)
FIGUREÂ 16Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)
FIGURE 17 ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)
FIGUREÂ 18Â ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 19 PORTER’S FIVE FORCE MODEL
FIGUREÂ 20Â PREVALENCE OF MENTAL HEALTH DISORDERS ACROSS THE GLOBE BETWEEN PERIOD 2012 AND 2020 (MILLION)
FIGUREÂ 21Â RISING GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)
FIGUREÂ 22Â VALUE CHAIN OF NEUROSTIMULATION DRUGS
FIGUREÂ 23Â INDIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGUREÂ 24Â CHINA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGUREÂ 25Â JAPAN NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGUREÂ 26Â AUSTRALIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGUREÂ 27Â SOUTH KOREA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE Â 28Â REST OF ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGUREÂ 29Â NEUROSTIMULATION DEVICE COMPANY MARKET SHARE 2018 (%)
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- MARKET BY SYSTEM
- SPINAL CORD STIMULATORS (SCS)
- DEEP BRAIN STIMULATORS (DBS)
- SACRAL NERVE STIMULATORS (SNS)
- VAGUS NERVE STIMULATORS (VNS)
- GASTRIC ELECTRIC STIMULATOR
- OTHER SYSTEM
- MARKET BY APPLICATIONS
- PAIN MANAGEMENT
- EPILEPSY
- ESSENTIAL TREMOR
- URINARY AND FECAL INCONTINENCE
- DEPRESSION
- DYSTONIA
- GASTROPARESIS
- PARKINSON’S DISEASE
- OTHER APPLICATIONS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.